AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $100,000 | -15.3% | 14,569 | 0.0% | 0.02% | +15.4% |
| Q4 2021 | $118,000 | -78.5% | 14,569 | -74.0% | 0.01% | -81.7% |
| Q3 2021 | $549,000 | -24.2% | 56,069 | -47.9% | 0.07% | -12.3% |
| Q2 2021 | $724,000 | +86.1% | 107,620 | +150.0% | 0.08% | +113.2% |
| Q1 2021 | $389,000 | -36.9% | 43,051 | -53.3% | 0.04% | -30.9% |
| Q4 2020 | $616,000 | +32.5% | 92,224 | 0.0% | 0.06% | +31.0% |
| Q3 2020 | $465,000 | -20.4% | 92,224 | +27.7% | 0.04% | -30.0% |
| Q2 2020 | $584,000 | +4.1% | 72,224 | +2.2% | 0.06% | -17.8% |
| Q1 2020 | $561,000 | +85.8% | 70,673 | +76.7% | 0.07% | +121.2% |
| Q4 2019 | $302,000 | – | 40,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |